Apixaban, an oral, direct, selective factor Xa inhibitor, in combination with antiplatelet therapy after acute coronary syndrome: results of the Apixaban for Prevention of Acute Ischemic and Safety Events (APPRAISE) trial
scientific article published on 26 May 2009
Author/s
author: Gilles Montalescot, Lars Wallentin, Robert A Harrington, Freek Verheugt, Deepak L. Bhatt, Witold Rużyłło, John H. Alexander, Richard C Becker, Shaun G Goodman, Keith Fox, Steen E Husted, Jose Luis López-Sendón Moreno, Mikhail Ruda, Puneet Mohan, Frank Cools, Mikael Dellborg
Work details
Copyright status
Copyright status information is not available for this work. The copyright status depends on the jurisdiction, the author's date of death and the date the work was created or published.
To learn more about copyright terms in different countries, visit the countries and terms page.